YURAK KASALLIKLARIDA MIKROORGANIZMLARNING ROLI: INFEKTSIYA, MIKROBIOM VA YALLIG‘LANISH MEXANIZMLARI
DOI:
https://doi.org/10.5281/zenodo.17959865Keywords:
bakteriya, virus, mikrobiom, yurak, ateroskleroz, yallig‘lanish, immunitet, infeksiya, metabolit, mikroorganizmlarAbstract
Yurak-qon tomir kasalliklari (YKTs) dunyo bo‘yicha eng ko‘p uchraydigan sog‘liq muammolaridan biri hisoblanadi. So‘nggi tadqiqotlar shuni ko‘rsatadiki, mikroorganizmlar — bakteriya, virus va hatto ichak mikrobiomining tarkibi — yurak salomatligiga sezilarli ta’sir ko‘rsatadi. Ushbu maqolada yurak kasalliklarida mikroorganizmlarning roli keng qamrovli tahlil qilinadi. Birinchi bo‘limda bakterial va viral infektsiyalarning yurak faoliyatiga ta’siri o‘rganiladi. Masalan, Streptococcus turidagi bakteriyalar revmatik yurak kasalligini keltirib chiqarishi, Chlamydia pneumoniae esa ateroskleroz rivojlanishida hissa qo‘shishi mumkinligi qayd etiladi. Ikkinchi bo‘lim ichak mikrobiomining yurak-qon tomir kasalliklariga ta’sirini muhokama qiladi.
References
Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5(11):685–694.
Epstein SE, Zhu J, Najafi AH, Burnett MS. Chlamydia pneumoniae and atherosclerosis: causal or casual association? Circulation. 1998;97(2):140–142.
Franceschi F, Zuccalà P, Gasbarrini A. Helicobacter pylori infection and atherosclerosis. Intern Emerg Med. 2014;9(6):707–714.
Kindermann I, Barth C, Mahfoud F, Ukena C, Lenski M, Yilmaz A, Klingel K, Kandolf R, Böhm M, Cooper LT. Update on myocarditis. J Am Coll Cardiol. 2008;59(9):779–792.
Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57–63.
Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, et al. Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med.
Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868–874.
Tsementzi D, Papatheodorou E, Konstantinidis KT. Microbiome and cardiovascular disease. Curr Opin Biotechnol.
Jonsson AL, Bäckhed F. Role of gut microbiota in atherosclerosis. Nat Rev Cardiol.
